CD147 expression indicates unfavourable prognosis in prostate cancer (Q43968053)

28 November 2017

title

CD147 expression indicates unfavourable prognosis in prostate cancer (English)

1 reference

28 November 2017

11

1 reference

28 November 2017

Zhao-dong Han

1

1 reference

28 November 2017

Xue-cheng Bi

2

1 reference

28 November 2017

Wei-jun Qin

3

1 reference

28 November 2017

Hui-chan He

4

1 reference

28 November 2017

Qi-shan Dai

5

1 reference

28 November 2017

Jun Zou

6

1 reference

28 November 2017

Yong-kang Ye

7

1 reference

28 November 2017

Yu-xiang Liang

8

1 reference

28 November 2017

Guo-hua Zeng

9

1 reference

28 November 2017

Zhi-nan Chen

10

1 reference

28 November 2017

publication date

1 September 2009

1 reference

Pathology and Oncology Research

28 November 2017

published in

1 reference

28 November 2017

volume

15

1 reference

28 November 2017

issue

3

1 reference

28 November 2017

page(s)

369-374

1 reference

Differential expression of extracellular matrix metalloproteinase inducer (CD147) in normal and ulcerated corneas: role in epithelio-stromal interactions and matrix metalloproteinase induction.

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12253-008-9131-Z

Inhibitory effects of antisense RNA of HAb18G/CD147 on invasion of hepatocellular carcinoma cellsin vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-008-9131-Z

Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-008-9131-Z

The precrystalline cytoplasmic granules of alveolar soft part sarcoma contain monocarboxylate transporter 1 and CD147.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-008-9131-Z

Tumorigenic potential of extracellular matrix metalloproteinase inducer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-008-9131-Z

Tumor cell stimulation of collagenase production by fibroblasts

21 January 2018

1 reference

12 December 2020

Emmprin promotes anchorage-independent growth in human mammary carcinoma cells by stimulating hyaluronan production

1 reference

12 December 2020

Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions

1 reference

12 December 2020

Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression

1 reference

12 December 2020

The importance of determining the aggressiveness of prostate cancer using serum and tissue molecular markers

1 reference

12 December 2020

Up-regulation of CD147 and matrix metalloproteinase-2, -9 induced by P-glycoprotein substrates in multidrug resistant breast cancer cells

1 reference

12 December 2020

MUC1, MUC2, MUC4, MUC5AC and MUC6 Expression in the Progression of Prostate Cancer

1 reference

12 December 2020

A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity.

1 reference

12 December 2020

Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN.

1 reference

12 December 2020

Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases

1 reference

12 December 2020

Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway

1 reference

12 December 2020

The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily

1 reference

12 December 2020

The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression

1 reference

12 December 2020

[Biological markers of prostate cancer]

1 reference

12 December 2020

Inhibition of CD147 expression reduces tumor cell invasion in human prostate cancer cell line via RNA interference

1 reference

12 December 2020

The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions

1 reference

12 December 2020

Thrombin-cleaved COOH(-) terminal osteopontin peptide binds with cyclophilin C to CD147 in murine breast cancer cells

1 reference

12 December 2020

A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer

1 reference

12 December 2020

The issue of prostate cancer evaluation in men with elevated prostate-specific antigen and chronic prostatitis

1 reference

12 December 2020

What to do with an abnormal PSA test.

1 reference

12 December 2020

Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells

1 reference

12 December 2020

Screening for prostate cancer: evidence and perspectives

1 reference

12 December 2020

High incidence of EMMPRIN expression in human tumors

1 reference

12 December 2020

EMMPRIN-mediated MMP regulation in tumor and endothelial cells

1 reference

12 December 2020

Watchful waiting as a treatment option for localized prostate cancer in the PSA era.

1 reference

12 December 2020

Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts

1 reference

12 December 2020

CD147 regulates vascular endothelial growth factor-A expression, tumorigenicity, and chemosensitivity to curcumin in hepatocellular carcinoma

1 reference

12 December 2020

10.1007/S12253-008-9131-Z

Identifiers

DOI

1 reference

28 November 2017

1 reference